日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Direct observation of small molecule activator binding to single PR65 protein

直接观察小分子激活剂与单个 PR65 蛋白的结合

Annie Yang-Schulz #, Maria Zacharopoulou #, Sema Zeynep Yilmaz, Anupam Banerjee, Satyaki Saha, Daniel Nietlispach, Michael Ohlmeyer, Mert Gur, Laura S Itzhaki, Ivet Bahar, Reuven Gordon

PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma

PP2A 激活可克服 3 组髓母细胞瘤中的软脑膜播散

Nazia Nazam, Michael H Erwin, Janet R Julson, Colin H Quinn, Andee M Beierle, Laura V Bownes, Jerry E Stewart, Kyung-Don Kang, Swatika Butey, Elizabeth Mroczek-Musulman, Michael Ohlmeyer, Elizabeth A Beierle

Diffusion-Weighted Imaging for Skin Pathologies of the Breast-A Feasibility Study

扩散加权成像在乳腺皮肤病变中的应用——一项可行性研究

Skwierawska, Dominika; Laun, Frederik B; Wenkel, Evelyn; Kapsner, Lorenz A; Janka, Rolf; Uder, Michael; Ohlmeyer, Sabine; Bickelhaupt, Sebastian

Novel PP2A-Activating Compounds in Neuroblastoma

神经母细胞瘤中的新型 PP2A 激活化合物

Nazia Nazam, Laura V Bownes, Janet R Julson, Colin H Quinn, Michael H Erwin, Raoud Marayati, Hooper R Markert, Sorina Shirley, Jerry E Stewart, Karina J Yoon, Jamie Aye, Michael Ohlmeyer, Elizabeth A Beierle

Lesion-mimicking DIXON swap artifact in contrast-enhanced subtraction breast MRI

对比增强减影乳腺磁共振成像中类似病灶的DIXON交换伪影

Bickelhaupt, Sebastian; Laun, Frederik Bernd; Uder, Michael; Ohlmeyer, Sabine

PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells

PP2A 为基础的三重疗法克服脑癌细胞的线粒体凋亡抵抗

Oxana V Denisova, Joni Merisaari, Riikka Huhtaniemi, Xi Qiao, Laxman Yetukuri, Mikael Jumppanen, Amanpreet Kaur, Mirva Pääkkönen, Сarina von Schantz-Fant, Michael Ohlmeyer, Krister Wennerberg, Otto Kauko, Raphael Koch, Tero Aittokallio, Mikko Taipale, Jukka Westermarck

Small-Molecule Activation of Protein Phosphatase 2A Counters Bleomycin-Induced Fibrosis in Mice

小分子激活蛋白磷酸酶 2A 可对抗小鼠博来霉素诱导的纤维化

Meshach Pillai, Pascale Lafortune, Abdoulaye Dabo, Howard Yu, Sangmi S Park, Harsha Taluru, Huma Ahmed, Dylan Bobrow, Zeeshan Sattar, Bakr Jundi, Joshua Reece, Romy Rodriguez Ortega, Brian Soto, Selome Yewedalsew, Robert Foronjy, Anne Wyman, Patrick Geraghty, Michael Ohlmeyer

Low-Risk Women with Suspicious Microcalcifications in Mammography-Can an Additional Breast MRI Reduce the Biopsy Rate?

乳房X光检查发现可疑微钙化的低风险女性——额外的乳房MRI检查能否降低活检率?

Pöschke, Patrik; Wenkel, Evelyn; Hack, Carolin C; Beckmann, Matthias W; Uder, Michael; Ohlmeyer, Sabine

The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma

新型三环磺胺类药物激活蛋白磷酸酶 2A 对肝母细胞瘤的影响

Laura V Bownes, Janet R Julson, Colin H Quinn, Sara Claire Hutchins, Michael H Erwin, Hooper R Markert, Jerry E Stewart, Elizabeth Mroczek-Musulman, Jamie Aye, Karina J Yoon, Michael Ohlmeyer, Elizabeth A Beierle

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

开发多激酶抑制剂 (AToMI) 筛选平台的可操作靶点,以剖析胶质母细胞瘤细胞中星形孢菌素的激酶靶点

Oxana V Denisova, Joni Merisaari, Amanpreet Kaur, Laxman Yetukuri, Mikael Jumppanen, Carina von Schantz-Fant, Michael Ohlmeyer, Krister Wennerberg, Tero Aittokallio, Mikko Taipale, Jukka Westermarck